Rocket Pharmaceuticals (RCKT) Amortizatization of Intangibles (2016 - 2026)

Rocket Pharmaceuticals has reported Amortizatization of Intangibles for 10 years, with the latest figure at $1.2 million in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 43.88% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 15.58% YoY) and the FY2025 annual result came in at $7.3 million, down 9.67% from the prior year.
• Amortizatization of Intangibles grew to $1.2 million in Q1 2026 per RCKT's latest filing, from $1.2 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $3.3 million in Q4 2023 and troughed at -$577000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2024 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles jumped 1560.9% in 2023, then sank 62.66% in 2024.
• Over 5 years, Amortizatization of Intangibles stood at $1.1 million in 2022, then jumped by 202.96% to $3.3 million in 2023, then tumbled by 62.66% to $1.2 million in 2024, then decreased by 1.23% to $1.2 million in 2025, then rose by 1.74% to $1.2 million in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.2 million, $1.2 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.